Ian M. Silverman

Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle

David W. Frederick, Emanuele Loro, Ling Liu et al. · Cell Metabolism · 2016 · 378 citations · Full text

Life Sciences, Biochemistry, Physiology +16

Clinicogenomic Analysis of <i>FGFR2</i> -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Ian M. Silverman, Antoine Hollebecque, Luc Friboulet et al. · Cancer Discovery · 2020 · 284 citations · Full text

Medicine, Oncology, Pharmacology +17

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

Vivek Subbiah, Nicholas Iannotti, Martin Gutierrez et al. · Annals of Oncology · 2022 · 197 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

HAMR: high-throughput annotation of modified ribonucleotides

Paul Ryvkin, Yuk Yee Leung, Ian M. Silverman et al. · RNA · 2013 · 147 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +12

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko et al. · Nature · 2022 · 130 citations · Full text

Medicine, Genetics, Oncology +17